Results for Fibrosis

1 - 10 of 56

Dr. Rubenstein's research focuses on basic and translational studies of novel means to improve outcomes in cystic fibrosis. He initially focused on correcting the dysfunction of mutant cystic fibrosis transmembrane conductance regulator (CFTR) proteins, which led him to study how molecular chaperones regulate the biogenesis and trafficking of CFTR and other proteins that are relevant to cystic fibrosis.

E-mail:

rubensteinr [at] chop.edu

Clement L. Ren, MD, MBA, ATSF

Dr. Ren's primary research focus is to develop better methods to assess lung disease in infants and young children using advanced pulmonary function testing and imaging.

E-mail:

renc [at] chop.edu

Suzanne E. Beck, MD

E-mail:

becksu [at] chop.edu

Virginia A. Stallings, MD

Dr. Stallings is working on intervention trials involving three chronic diseases with nutrition-related abnormalities resulting in meaningful adverse outcomes: cystic fibrosis (new drugs), sickle cell disease (vitamin A) and chronic pancreatitis (enzyme replacement drug).

E-mail:

stallingsv [at] chop.edu

Maria R. Mascarenhas, MBBS

Dr. Mascarenhas is director of the Nutrition Support Service, section chief of nutrition in the Division of Gastroenterology and Nutrition, medical director of the Clinical Nutrition Department, and director of the Integrative Health Program. Her research interests involve 22q deletion syndrome, cystic fibrosis, nutrition, and integrative medicine.

E-mail:

mascarenhas [at] chop.edu

Amanda B. Muir, MD

Dr. Muir investigates the mechanisms underlying esophageal fibrosis to improve therapeutic and diagnostic approaches.

E-mail:

muira [at] chop.edu

Jessica W. Wen, MD

Dr Jessica Wen is director of the Viral Hepatitis Treatment Program and a pediatric gastroenterologist at Children's Hospital of Philadelphia. She also works with CHOP's Liver Transplant Program and the Biesecker Pediatric Liver Center. Her research focuses on hepatitis B and C, and liver fibrosis.

E-mail:

wenj [at] chop.edu

Samuel B. Goldfarb, MD

Dr. Goldfarb has special interests in the treatment of children with end-stage lung disease such as cystic fibrosis, interstitial lung disease, pulmonary late effects of oncology treatments, and other pulmonary disorders.

E-mail:

goldfarb [at] chop.edu

Dah-Jyuu Wang, PhD

Dr. Wang works on biomarker identification using multiparametric magnetic resonance imaging and homo- and hetero-nuclear spectroscopy techniques for pediatric disease research including tumors, iron overload, cystic fibrosis, muscular dystrophy, autism, mitochondrial, Gaucher’s, and Canavan’s diseases.

E-mail:

wangd [at] chop.edu

Andrea Kelly, MD, MSCE

Dr. Kelly is an attending physician in the Division of Endocrinology and Diabetes at Children's Hospital of Philadelphia and a professor of pediatrics at the University of Pennsylvania. Her research focuses on cystic fibrosis, bone and body composition, and endocrine co-morbidities in Down syndrome.

E-mail:

kellya [at] chop.edu